The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib/II study of ALT-803 in combination with gemcitabine and nab-paclitaxel in patients with advanced pancreatic cancer.
 
Jared David Acoba
Research Funding - Merck (I)
Travel, Accommodations, Expenses - Merck
 
Amy Rock
Employment - Altor BioScience
 
Hing C. Wong
Employment - Altor BioScience
Leadership - Altor BioScience